Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists

Bene, Judit; Dubart, Alain-Eric; Senis, C.; Auffret, Marine; Caron, J; Gautier, S. V.

doi:10.1016/j.jmv.2014.04.002

Cited by 1 publication

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prescription of VKAs is rendered difficult by the existence of a large inter‐individual variability in treatment response and a narrow therapeutic index . Bleeding is the major complication of VKAs therapy and VKAs response variability is partly due to comorbidities, food and drug interactions and pharmacogenetic factors . Despite their similar structure, the pharmacokinetic profiles of coumarin derivatives are different and well described, while pharmacokinetic data about indanedione derivatives are still scarce .…”

Section: Introductionmentioning

confidence: 99%

Role of ABC transporters in trans‐epithelial transport of vitamin K antagonists

Espana

Couturier

Prouillac

2017

Biopharm & Drug Disp

View full text Add to dashboard Cite

Vitamin K antagonists (VKAs) remain the oral anticoagulant of choice in venous thromboembolic disease. These drugs are characterized by a large inter-individual variability requiring frequent dose tailoring. Genetic polymorphisms for cytochrome CYP2C9 and VKORC1 explain some of the variability, especially in warfarin and acenocoumarol responses. The aim of this study was to assess, in cell models, the role of ABC transporters in the intestinal transfer of the main coumarin derivatives (warfarin, acenocoumarol) and indanedione derivatives (phenindione, fluindione). The results show a basal to apical polarized transport for fluindione, phenindione and acenocoumarol only. Experimental studies using specific inhibitors of transport protein demonstrate the implication of MRPs and BCRP proteins and to a lesser extent P-gp. Warfarin and acenocoumarol seem to be poor inhibitors of MRPs protein, whereas fluindione and phenindione have a slight or no effect. The regulation of the expression of ABC transporters by exposure to VKAs was also investigated in Caco-2 cells. The expression of mRNA P-gp, MRP1, MRP2 and BCRP was weakly or not modified after 24 h of VKAs exposure. In conclusion, the intestinal transfer of indanedione derivatives and acenocoumarol could be influenced by transport proteins of the ABC superfamily. Coumarin derivatives are poor inhibitors of these proteins and AVKs have a slight effect on the mRNA ABC transporter expression level. Copyright © 2016 John Wiley & Sons, Ltd.

show abstract

Section: Introductionmentioning

confidence: 99%